id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-0026-0024,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2023-12-05T05:00:00Z,2023,12,2023-12-05T05:00:00Z,,2023-12-05T17:53:57Z,2023-26652,0,0,09000064862f4366
FDA-2020-N-0026-0023,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,General Notice,2023-06-06T04:00:00Z,2023,6,2023-06-06T04:00:00Z,,2023-06-06T13:56:37Z,2023-11907,0,0,0900006485ac482e
FDA-2020-N-0026-0022,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2023-04-24T04:00:00Z,2023,4,2023-04-24T04:00:00Z,,2023-04-24T13:13:08Z,2023-08518,0,0,090000648597a166
FDA-2020-N-0026-0021,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2023-03-30T04:00:00Z,2023,3,2023-03-30T04:00:00Z,,2023-03-30T17:50:15Z,2023-06593,0,0,090000648588ded3
FDA-2020-N-0026-0020,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,General Notice,2023-03-16T04:00:00Z,2023,3,2023-03-16T04:00:00Z,,2023-03-16T14:40:38Z,2023-05364,0,0,09000064857b8ed4
FDA-2020-N-0026-0019,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,General Notice,2023-03-16T04:00:00Z,2023,3,2023-03-16T04:00:00Z,,2023-03-16T14:29:35Z,2023-05355,0,0,09000064857b8f16